Protein tyrosine phosphatase SHP2 suppresses podosome rosette formation in Src-transformed fibroblasts

Yi-Ru Pan1, Ke-Huan Cho, Hsiao-Hui Lee

  • 1Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan.

Journal of Cell Science
|November 27, 2012
PubMed

Insights

The Src homolog domain-containing phosphatase 2 (SHP2) inhibits podosome rosette formation. SHP2 dephosphorylates Tks5 and activates ROCK, promoting vimentin polymerization, which suppresses podosome assembly in fibroblasts.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Podosomes are actin-rich structures crucial for cell invasion and extracellular matrix degradation.
  • Podosome rosettes form in specific cell types, including cancer cells, but the role of phosphatases is unclear.
  • Protein tyrosine kinases are implicated in podosome rosette formation, yet phosphatases remain understudied.

Purpose of the Study:

  • To investigate the role of Src homolog domain-containing phosphatase 2 (SHP2) in regulating podosome rosette formation.
  • To elucidate the molecular mechanisms by which SHP2 influences podosome assembly.

Main Methods:

  • Utilized knockdown and overexpression of SHP2 in Src-transformed fibroblasts.
  • Assessed podosome rosette formation and vimentin polymerization.
  • Analyzed tyrosine phosphorylation of Tks5 and Rho-associated kinase (ROCK) activation.

Main Results:

  • SHP2 knockdown increased podosome rosette formation, while SHP2 overexpression suppressed it.
  • SHP2's phosphatase activity was essential for inhibiting podosome rosettes.
  • SHP2 dephosphorylated Tks5, activated ROCK, and enhanced vimentin polymerization, inversely correlating with podosome rosettes.

Conclusions:

  • SHP2 acts as a negative regulator of podosome rosette formation in Src-transformed fibroblasts.
  • SHP2's mechanism involves Tks5 dephosphorylation and ROCK-mediated vimentin polymerization.
  • These findings highlight SHP2's critical role in controlling cell invasion-related structures.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...